These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25721024)
1. In silico studies, synthesis and binding evaluation of substituted 2-pyrrolidinones as peptidomimetics of RGD tripeptide sequence. Toum V; Bolley J; Lalatonne Y; Barbey C; Motte L; Lecouvey M; Royer J; Dupont N; Pérard-Viret J Eur J Med Chem; 2015 Mar; 93():360-72. PubMed ID: 25721024 [TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD and Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382 [TBL] [Abstract][Full Text] [Related]
3. Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling. Vasile F; Menchi G; Lenci E; Guarna A; Potenza D; Trabocchi A Bioorg Med Chem; 2016 Mar; 24(5):989-94. PubMed ID: 26818999 [TBL] [Abstract][Full Text] [Related]
4. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics. Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088 [TBL] [Abstract][Full Text] [Related]
5. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies. Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523 [TBL] [Abstract][Full Text] [Related]
6. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand. Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617 [TBL] [Abstract][Full Text] [Related]
7. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404 [TBL] [Abstract][Full Text] [Related]
8. Stereodivergent synthesis of 5-aminopipecolic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar α Sernissi L; Ricci L; Scarpi D; Bianchini F; Arosio D; Contini A; Occhiato EG Org Biomol Chem; 2018 May; 16(18):3402-3414. PubMed ID: 29675532 [TBL] [Abstract][Full Text] [Related]
9. Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity. Neubauer S; Rechenmacher F; Brimioulle R; Di Leva FS; Bochen A; Sobahi TR; Schottelius M; Novellino E; Mas-Moruno C; Marinelli L; Kessler H J Med Chem; 2014 Apr; 57(8):3410-7. PubMed ID: 24654918 [TBL] [Abstract][Full Text] [Related]
10. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake. Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540 [TBL] [Abstract][Full Text] [Related]
11. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378 [TBL] [Abstract][Full Text] [Related]
12. High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging α Piras M; Testa A; Fleming IN; Dall'Angelo S; Andriu A; Menta S; Mori M; Brown GD; Forster D; Williams KJ; Zanda M ChemMedChem; 2017 Jul; 12(14):1142-1151. PubMed ID: 28608961 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
14. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating. Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759 [TBL] [Abstract][Full Text] [Related]
15. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands. Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988 [TBL] [Abstract][Full Text] [Related]
16. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion. Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802 [TBL] [Abstract][Full Text] [Related]
18. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. Choi Y; Kim E; Lee Y; Han MH; Kang IC Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657 [TBL] [Abstract][Full Text] [Related]